Hospitalist Doctors in Bismarck, ND Accepting Medicare

9 Hospitalist doctors found. Showing 1 - 9

Todd A Twogood, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000    Fax: 701-323-5884

Dr. Issa Y Al Rabadi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000

Dr. Candice Danielle Marilyn Crichlow, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Dwpt Of Internal Medicine, Bismarck, ND 58501 Phone: 701-323-6000

Dr. Taleb Taha, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-5000

Dr. Opeyemi M. Ajayi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000

Lawrence J Dasilva, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 222 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000    Fax: 701-323-5709

Renae Welhouse, ACNPC-AG Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 300 N 7th St, Bismarck, ND 58501 Phone: 701-323-6000

Dr. Khris R Ramdeen, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Suite 4161, Bismarck, ND 58501 Phone: 701-530-3894

Dr. J'patrick C Fahn, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 900 E Broadway Ave, Bismarck, ND 58501 Phone: 701-530-7000

News Archive

Celling Technologies and SpineSmith team up to research adipose tissue derived stem cell applications

Celling Technologies, a subsidiary of SpineSmith Partners, is collaborating with Tissue Genesis, Inc. to research potential applications for adipose tissue derived adult stem cells. SpineSmith acquired the global rights in spine for Tissue Genesis' adipose (fat) tissue derived stem cell technology in November of 2007.

Aaxillary lymph node dissection and radiotherapy provide excellent regional control for patients with breast cancer

Final analysis of the EORTC 10981-22023 AMAROS (After Mapping of the Axilla: Radiotherapy Or Surgery?) trial has shown that both axillary lymph node dissection and axillary radiotherapy provide excellent regional control for breast cancer patients with a positive sentinel node biopsy

New mobile safety center hits the streets of Baltimore

The Johns Hopkins Bloomberg School of Public Health, Johns Hopkins Medical Institutions and the Baltimore City Fire Department are launching the Johns Hopkins CARES Mobile Safety Center to keep children safe from unintentional injury, which is the leading cause of death for children nationwide.

Results announced for Phase 3B/4 study of RAPAMUNE in kidney transplant patients

Pfizer Inc. (NYSE:PFE) announced today top-line results from a Phase 3B/4 study of RAPAMUNE® (sirolimus) evaluating kidney transplant patients who transitioned from tacrolimus-based therapy (TAC) to RAPAMUNE® 3 to 5 months after transplant.

Read more Medical News

› Verified 2 days ago